PR Newswire Asia's news > Health Care/Hospital

 < Previous page   |   Title only   |   Print    Next page > 
     
Sarawak Secures Landmark Win to Host APAC's Leading Lung Disease Conference in 2028
KUCHING, Malaysia , April 27, 2026 /PRNewswire/ -- Sarawak has won hosting rights for the 11th Asia Pacific Regional Conference 2028 (APRC 2028) of the International Union Against Tuberculosis and Lung ...
2026-04-27T    Health Care/Hospital   Medical/Pharmaceuticals   Trade show news 
AHG Announces Initiation of World-Class, Proprietary Brain-Computer Interface R&D Program - Targeting the Next Frontier of Human Neurotechnology
QINGDAO, China , April 27, 2026 /PRNewswire/ -- Akso Health Group (NASDAQ: AHG) ("Akso Health" or the "Company") today announced the commencement of its next-generatio n, proprietary ...
2026-04-27T    Computer/Electronics   Health Care/Hospital   Medical/Pharmaceuticals 
Classys Emerges as a Global Leader in Medical Aesthetics Beyond K-Beauty, Highlighting 45% Growth, 50%+ Margins, and Recurring Revenue Model
– Operations in 80+ countries with over 45,000 installed platforms and 66% international revenue mix – Consumables account for 46% of revenue, with more than 5.5 million HIFU procedures performed annually ...
2026-04-27T    Cosmetics & Personal Care   Health Care/Hospital   Household/Consumer/Cosmetics   Medical Equipment 
WuXi AppTec Delivers Strong Revenue and Profit Growth in Q1 2026
Total Revenue Reached RMB 12.44 Billion; Revenue from Continuing Operations Up 39.4% YoY Adjusted Non-IFRS Net Profit Up 71.7% YoY to RMB 4.60 Billion Backlog for Continuing Operations Up 23.6% ...
2026-04-27T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
IMG Pharma Enters into Definitive Agreement to Acquire Matsumoto Pharmaceutical
TOKYO , April 27, 2026 /PRNewswire/ -- IMG Pharmaceutical Co., Ltd. ("IMG Pharma"), a majority-owned subsidiary of IMG Japan, the Group's holding company, announced that it has entered into ...
2026-04-27T    Health Care/Hospital   Medical/Pharmaceuticals 
Eyebright Medical Releases Its 2025 Annual Report and Sustainability Report
Innovation Drives Strong Results, While Global Expansion and ESG Practices Progress Steadily ...
2026-04-27T    Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Ascletis Completes Enrollment in U.S. Phase II Study of ASC30, an Oral Small Molecule GLP-1R Agonist, for the Treatment of Diabetes
- 13-week U.S. Phase II study is evaluating the efficacy, safety and tolerability of oral small molecule GLP-1R agonist ASC30, a once-daily tablet, in 100 participants with diabetes. ...
2026-04-27T    Health Care/Hospital   Medical/Pharmaceuticals 
VARON Celebrates 5 Years Supporting Easier Breathing for Customers Worldwide
NEW YORK , April 27, 2026 /PRNewswire/ --  VARON is celebrating a meaningful milestone, its 5th anniversary , and is taking this moment to thank customers around the world who have trusted its ...
2026-04-27T    Computer/Electronics   Consumer Electronics   Electronic Commerce   Health Care/Hospital 
Brii Bio Presents Cross-Study Analysis of Post-Treatment HBsAg Rebound at APASL 2026
- Participants achieving HBsAg loss with pegylated interferon alfa (PEG-IFNα) ± elebsiran or BRII-179 demonstrated favorable off-treatment clinical outcomes, with most HBsAg rebounds <10 ...
2026-04-26T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
"Strengthening Foundations, Moving Forward Steadily": The 28th National Chinese Life Insurance Congress & 2026 IDA DAY Welcomes Over 2,800 Professionals to Sunway Pyramid Convention Centre, Kuala Lumpur
KUALA LUMPUR, Malaysia , April 25, 2026 /PRNewswire/ -- In an era of persistent global economic turbulence and accelerated industry transformation, the insurance sector is evolving beyond its traditional ...
2026-04-25T    Banking/Financial Service   Health Care/Hospital   Insurance 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.